In the News.. Tandem buys a patch pump, Insulin pump equity, Lilly loses a partner, and more!

It's In the News, a look at the top stories from the diabetes community from the last seven days. This week: Tandem buys the maker of Sigi Pump, a reusable, rechargable patch pump, Lilly uncouples from Ypsomed, big study finds widespread adoption of insulin pumps among people with type 1, but not among people of color, a big look at vegetables studies and why potatoes are basically messing things up.. and a lot more!

Check out Stacey's book: The World's Worst Diabetes Mom!

Join the Diabetes Connections Facebook Group!

Sign up for our newsletter here

Episode Transcription Below (or coming soon!)

Please visit our Sponsors & Partners - they help make the show possible!

*Click here to learn more about OMNIPOD*

*Click here to learn more about AFREZZA*

*Click here to learn more about DEXCOM*

Hello and welcome to Diabetes Connections In the News! I’m Stacey Simms and these are the top diabetes stories and headlines of the past seven days.
XX
In the news is brought to you by T1D Exchange! T1D Exchange is a nonprofit organization dedicated to improving outcomes for the entire T1D population.
https://t1dexchange.org/stacey/
XX
Big new study about insulin pumps shows white patients are twice as likely to get one as Black patients, and better-educated, wealthier people are also more likely to be using one. Over 20 years, starting in 2001, these researchers saw a large increase in insulin pump use across all patients, but no change in distribution by race or socioeconomic status
The study was recently published in the journal Diabetes Technology & Therapeutics. Recent data found that Black people had higher rates of severe diabetes-related complications compared with white folks.
There is also a concern that these gaps will widen with the new automated insulin-delivery systems, worsening health inequality for subsets of youth with type 1 diabetes.

https://www.usnews.com/news/health-news/articles/2022-12-13/insulin-pumps-ease-diabetes-care-so-why-are-black-patients-less-likely-to-get-one
XX
Tandem Diabetes snaps up a patch pump.. buying the Swiss company that makes Sigi. The Sigi Patch Pump is not yet available, it has FDA breakthrough designation. This is a rechargeable pump, you get two you can switch out, and the infusion set is disposable. It’s set up to work with an AID system. We did an episode with SIGI earlier this year.. no word on what this might mean for Tandem’s Mobi pump.. which is a tubed pump that’s very small and was meant to compete with Omnipod.. before this news.

https://www.businesswire.com/news/home/20221213005314/en/Tandem-Diabetes-Care-to-Acquire-Insulin-Patch-Pump-Developer-AMF-Medical
XX
Eli Lilly has pulled out of a partnership with Ypsomed that would have given it a branded insulin pump to sell in the U.S.
Lilly struck a deal two years ago to commercialize YpsoPump under its own brand in the U.S. The partners have since worked to customize the pump, which has been sold in Europe since 2016, for the U.S. market.
Ypsomed plans to push ahead with the U.S. expansion without Lilly, outlining plans to file with the Food and Drug Administration in the second half of next year